Marcia Belvin Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Marcia Belvin is SVP, Chief Scientific Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 263,148 shares of CTMX, which is worth approximately $242,096. The most recent transaction as insider was on Feb 04, 2025, when has been sold 87,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
263K
49.82%
3M change
45.09%
12M change
Total Value Held
$242,096
MARCIA BELVIN Transaction History
MB
Marcia Belvin
SVP, Chief Scientific Officer
South San Francisco, CA